Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8425)
All Articles published online
|
Publishing Process of This Article
|
May 27, 2020 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Faust N, Yamada A, Haider H, Komaki Y, Komaki F, Micic D, Sakuraba A. Systemic review and network meta-analysis: Prophylactic antibiotic therapy for spontaneous bacterial peritonitis. World J Hepatol 2020; 12(5): 239-252 [PMID: 32547691 DOI: 10.4254/wjh.v12.i5.239] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i5/239.htm |
| Number | Citing Articles |
| 1 |
Tahir Zaman, Muhammad Bilal Ahmed Attari, Adeel Ahmad, Muhammad Ahsan Butt, Khurram Fayyaz, Syeda Aeman Zubair. Comparison of Rifaximin Alone and With Quinolones in the Primary Prevention of Spontaneous Bacterial Peritonitis in Patients With Decompensated Chronic Liver Disease. Cureus 2024; doi: 10.7759/cureus.55251
|
| 2 |
S. S. Kuzminykh, O. V. Makarenko . Pharmacoeconomic Analysis of N-Chlorotaurine Infusion Therapy in the Treatment of Patients with Peritonitis. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2022; 7(5): 114 doi: 10.26693/jmbs07.05.114
|
| 3 |
Petros Ioannou, Stamatis Karakonstantis, Jeroen Schouten, Tomislav Kostyanev, Esmita Charani, Vera Vlahovic-Palcevski, Diamantis P. Kofteridis. Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review. Clinical Microbiology and Infection 2022; 28(3): 362 doi: 10.1016/j.cmi.2021.10.001
|
| 4 |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Abstract(643) |
Core Tip(575) |
Full Article(HTML)(3324)
|
Full Article with Cover (PDF)-2077K(108)
|
Full Article (Word)-351K(59)
|
Audio-395K(9)
|
Peer-Review Report-291K(64)
|
Answering Reviewers-97K(75)
|
Full Article (PDF)-967K(303)
|
Full Article (XML)-396K(79)
|
Times Cited (12)
|
Total Visits (7248)
|
Open
|
| 5 |
Bálint Baráth, Dávid K. Jász, Tamara Horváth, Bence Baráth, Gergely Maróti, Gerda Strifler, Gabriella Varga, Lilla Sándor, Domonkos Perényi, Szabolcs Tallósy, Tibor Donka, Péter Jávor, Mihály Boros, Petra Hartmann. Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal Damage. International Journal of Molecular Sciences 2022; 23(9): 5064 doi: 10.3390/ijms23095064
|
| 6 |
Daniel Pörner, Sibylle Von Vietinghoff, Jacob Nattermann, Christian P Strassburg, Philipp Lutz. Advances in the pharmacological management of bacterial peritonitis. Expert Opinion on Pharmacotherapy 2021; 22(12): 1567 doi: 10.1080/14656566.2021.1915288
|
| 7 |
José M. Porcel. Expert Review on Contemporary Management of Common Benign Pleural Effusions. Seminars in Respiratory and Critical Care Medicine 2023; 44(04): 477 doi: 10.1055/s-0043-1769096
|
| 8 |
Mykola Tutchenko, Diana Rudyk, Mykola Besedinskyi, Sergey Chub. SPONTANEOUS BACTERIAL PERITONITIS. Eastern Ukrainian Medical Journal 2024; 12(2): 221 doi: 10.21272/eumj.2024;12(2):221-228
|
| 9 |
Federica Di Vincenzo, Alberto Nicoletti, Marcantonio Negri, Federica Vitale, Lorenzo Zileri Dal Verme, Antonio Gasbarrini, Francesca Romana Ponziani, Lucia Cerrito. Gut Microbiota and Antibiotic Treatments for the Main Non-Oncologic Hepato-Biliary-Pancreatic Disorders. Antibiotics 2023; 12(6): 1068 doi: 10.3390/antibiotics12061068
|
| 10 |
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
|
| 11 |
Aldo Torre, Jacqueline Córdova-Gallardo, Alberto C Frati Munari. Rifaximin Alfa and Liver Diseases: More Than a Treatment for Encephalopathy, a Disease Modifier. Therapeutics and Clinical Risk Management 2023; : 839 doi: 10.2147/TCRM.S425292
|